Journal article
The epidemiology and clinical burden of human adenovirus respiratory infections among hospitalized children under 5 years in Jordan
- Abstract:
-
Background:
Human Adenovirus (HAdV) is a significant pathogen associated with severe acute respiratory infections, especially in children under 5. Despite its global impact, its epidemiological and clinical burden in Jordan, particularly post-COVID-19, is limited.
Methods:
We conducted a multicenter cross-sectional study across 4 hospitals in Jordan from November 2022 to April 2023. Nasopharyngeal swabs were collected from children <5 years old hospitalized with respiratory symptoms. HAdV positivity was determined using real-time polymerase chain reaction. Demographic, clinical and laboratory data were analyzed to identify predictors of HAdV positivity and complications.
Results:
Among 1000 enrolled participants (median age 9.68 months, 59% male), the HAdV positivity rate was 10.9%, highest in children 49–60 months of age. HAdV-positive cases had higher rates and longer duration of sore throat compared with HAdV-negative cases. Coinfections with respiratory syncytial viruses or influenza were present in 34.9% of HAdV-positive cases and were associated with increased rates of cough, wheezing and respiratory crackles. Logistic regression revealed lower odds of HAdV positivity in children under six months [odds ratio (OR) 0.31, P < 0.001], while invasive ventilation was associated with higher odds of positivity (OR 5.01, P < 0.001). HAdV infection without coinfection was associated with reduced odds of complications (OR 0.06, P < 0.001).
Conclusions:
This is the first comprehensive study in Jordan to document the epidemiologic and clinical burden of HAdV in children post-COVID-19. HAdV remains a major cause of respiratory morbidity, with significant coinfection rates. Further research is needed to explore the nonrespiratory manifestations, identify HAdV common local serotypes and genetic characteristics.
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 3.9MB, Terms of use)
-
- Publisher copy:
- 10.1097/inf.0000000000005020
Authors
+ Mutah University
More from this funder
- Funder identifier:
- https://ror.org/008g9ns82
- Grant:
- 884/2024
+ MSD (UK) Limited (United Kingdom)
More from this funder
- Funder identifier:
- https://ror.org/004nn4n27
- Grant:
- 101057
- Publisher:
- Lippincott, Williams & Wilkins
- Journal:
- The Pediatric Infectious Disease Journal More from this journal
- Volume:
- 45
- Issue:
- 3
- Pages:
- 229-235
- Place of publication:
- United States
- Publication date:
- 2025-10-22
- Acceptance date:
- 2025-09-09
- DOI:
- EISSN:
-
1532-0987
- ISSN:
-
0891-3668
- Pmid:
-
41121498
- Language:
-
English
- Keywords:
- Pubs id:
-
2308407
- UUID:
-
uuid_80f09552-3b80-417e-82e0-06f589d24675
- Local pid:
-
pubs:2308407
- Deposit date:
-
2025-12-02
- ARK identifier:
Terms of use
- Copyright holder:
- Wolters Kluwer Health, Inc.
- Copyright date:
- 2025
- Rights statement:
- Copyright © 2025 Wolters Kluwer Health, Inc. All rights reserved.
- Notes:
- The author accepted manuscript (AAM) of this paper has been made available under the University of Oxford's Open Access Publications Policy, and a CC BY public copyright licence has been applied.
- Licence:
- CC Attribution (CC BY)
If you are the owner of this record, you can report an update to it here: Report update to this record